CareDx, Inc (NASDAQ:CDNA) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Ian Cooney - VP of IR Reg Seeto - CEO Ankur Dhingra - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Andrew Cooper - Raymond James Mason Carrico - Stephens Inc. Operator Good day, and welcome to the CareDx First Quarter 2022 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note this event is being recorded. I would now like to turn t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 _ ...

CareDx, Inc (NASDAQ:CDNA) Q4 2021 Earnings Conference Call February 24, 2022 4:30 PM ET Company Participants Ian Cooney - Vice President of Investor Relations Reg Seeto - President & Chief Executive Officer Ankur Dhingra - Chief Financial Officer Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Dipesh Patel - H.C. Wainwright Andrew Cooper - Raymond James Operator Thank you for standing by. This is the conference operator. Welcome to the CareDx, Inc. Fourth Quarter 2021 Earnings Conferenc ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________________________________ Form 10-K ________________________________________________________________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH ...

CareDx, Inc. (NASDAQ:CDNA) Q3 2021 Earnings Conference Call October 28, 2021 4:30 PM ET Company Participants Ian Cooney - Investor Relations Reg Seeto - President and Chief Executive Officer Ankur Dhingra - Chief Financial Officer Conference Call Participants Matt Sykes - Goldman Sachs Alex Nowak - Craig-Hallum Capital Group Mark Massaro - BTIG Andrew Cooper - Raymond James Yi Chen - H.C. Wainwright Operator Greetings, and welcome to the CareDx, Incorporated Third Quarter 2021 Earnings Conference Call. [Ope ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-365 ...

CareDX, Inc. (NASDAQ:CDNA) Q2 2021 Earnings Conference Call July 29, 2021 4:30 PM ET Company Participants Ian Cooney - Investor Relations Reg Seeto - President and Chief Executive Officer Ankur Dhingra - Chief Financial Officer Conference Call Participants Andrew Cooper - Raymond James Matt Sykes - Goldman Sachs Steven Mah - Piper Sandler Brandon Couillard - Jefferies Alex Nowak - Craig-Hallum Capital Group Mark Massaro - BTIG Yi Chen - H.C. Wainwright Operator Greetings, and welcome to the CareDx, Inc. Sec ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 __ ...

The Allo-Transplantation Company Focused on better outcomes through personalized transplant surveillance May 2021 Allo-transplant (allo- meaning "other" in Greek) is the transplantation of cells, tissues or organs to a recipient from a genetically non-identical donor of the same species Dx® Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements r ...

CareDx, Inc. (NASDAQ:CDNA) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Greg Chodaczek - Managing Director, Gilmartin Group Reginald Seeto - President and Chief Executive Officer Ankur Dhingra - Chief Financial Officer Conference Call Participants Brandon Couillard - Jefferies Andrew Cooper - Raymond James Alex Nowak - Craig-Hallum Capital Group Steven Mah - Piper Sandler Operator Greetings, and welcome to the CareDX, Inc. First Quarter 2021 Earnings Conference Call. At this ...